Comparison of Kendali Glycemia during and Post-Hospitalization in Covid-19 Patients with Diabetes Mellitus at AR Bunda Prabumulih Hospital

The study compared therapeutic modalities and changes in hypoglycemic agents with glycemia control seen from blood sugar levels and HbA1C in COVID-19 and Diabetes Mellitus patients. This study was followed at three months and six months post-COVID-19. This study is a prospective cohort study with a 3-point cross-sectional crossectional approach. Data is also taken from medical record data, followed by post-covid-19 months three and 6. In this study, it can be concluded that blood glucose levels during three months and six months after COVID-19 are still difficult to control, even though there has been a change in the therapeutic modality from OAD to insulin. There is a decrease in the average HbA1c levels three months after COVID-19 and six months after COVID-19, statistically means p.